Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
13.01
+0.09 (0.70%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Syndax Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 154.08 | 295.39 | 74.36 | 221.97 | 115.24 | Upgrade
|
| Short-Term Investments | 428.83 | 282.19 | 410.04 | 224.87 | 182.51 | Upgrade
|
| Cash & Short-Term Investments | 582.91 | 577.58 | 484.4 | 446.83 | 297.75 | Upgrade
|
| Cash Growth | 0.92% | 19.24% | 8.41% | 50.07% | 387.54% | Upgrade
|
| Accounts Receivable | 7.6 | - | - | - | - | Upgrade
|
| Other Receivables | 6.27 | 1.23 | 4.06 | 0.43 | 0.2 | Upgrade
|
| Receivables | 13.87 | 1.23 | 4.06 | 0.43 | 0.2 | Upgrade
|
| Inventory | 0.37 | - | - | - | 0.06 | Upgrade
|
| Prepaid Expenses | 5.3 | 2 | 1.22 | 0.87 | 0.43 | Upgrade
|
| Restricted Cash | - | - | - | 0.12 | 0.12 | Upgrade
|
| Other Current Assets | 0.61 | 0.06 | 0.12 | 0.15 | 0.32 | Upgrade
|
| Total Current Assets | 603.06 | 580.88 | 489.79 | 448.4 | 298.86 | Upgrade
|
| Property, Plant & Equipment | 2.02 | 1.5 | 1.06 | 1.26 | 0.48 | Upgrade
|
| Long-Term Investments | 119.52 | 29.83 | 5.47 | - | - | Upgrade
|
| Other Long-Term Assets | 0.22 | 0.68 | 0.92 | - | 1.27 | Upgrade
|
| Total Assets | 724.82 | 612.88 | 497.24 | 449.66 | 300.61 | Upgrade
|
| Accounts Payable | 11.63 | 9.96 | 4.35 | 5.67 | 3.51 | Upgrade
|
| Accrued Expenses | 59.68 | 38.97 | 23.67 | 12.76 | 11.25 | Upgrade
|
| Current Portion of Long-Term Debt | 12.12 | - | - | - | 2.29 | Upgrade
|
| Current Portion of Leases | 0.48 | 1.05 | 0.44 | 0.36 | 0.32 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | 1.52 | Upgrade
|
| Other Current Liabilities | 19.65 | 8.12 | 0.6 | 1.89 | - | Upgrade
|
| Total Current Liabilities | 103.55 | 58.1 | 29.07 | 20.68 | 18.87 | Upgrade
|
| Long-Term Debt | 331.57 | - | - | 19.9 | 17.83 | Upgrade
|
| Long-Term Leases | 1.58 | 0.59 | 0.72 | 0.71 | 0.1 | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | - | 11.62 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 0 | Upgrade
|
| Total Liabilities | 436.69 | 58.68 | 29.79 | 41.29 | 48.43 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 1,509 | 1,456 | 1,161 | 952.02 | 820.82 | Upgrade
|
| Retained Earnings | -1,221 | -902.4 | -693.04 | -543.7 | -568.63 | Upgrade
|
| Comprehensive Income & Other | 0.16 | 0.22 | -0.81 | 0.05 | -0 | Upgrade
|
| Total Common Equity | 288.12 | 554.2 | 467.45 | 408.37 | 252.19 | Upgrade
|
| Shareholders' Equity | 288.12 | 554.2 | 467.45 | 408.37 | 252.19 | Upgrade
|
| Total Liabilities & Equity | 724.82 | 612.88 | 497.24 | 449.66 | 300.61 | Upgrade
|
| Total Debt | 345.74 | 1.64 | 1.16 | 20.97 | 20.54 | Upgrade
|
| Net Cash (Debt) | 237.17 | 575.95 | 483.24 | 425.86 | 277.21 | Upgrade
|
| Net Cash Growth | -58.82% | 19.19% | 13.47% | 53.62% | 360.68% | Upgrade
|
| Net Cash Per Share | 2.77 | 8.18 | 7.95 | 7.94 | 6.71 | Upgrade
|
| Filing Date Shares Outstanding | 86.02 | 84.97 | 68.44 | 55.01 | 48.24 | Upgrade
|
| Total Common Shares Outstanding | 85.69 | 84.83 | 68.11 | 54.98 | 47.88 | Upgrade
|
| Working Capital | 499.51 | 522.78 | 460.72 | 427.71 | 279.99 | Upgrade
|
| Book Value Per Share | 3.36 | 6.53 | 6.86 | 7.43 | 5.27 | Upgrade
|
| Tangible Book Value | 288.12 | 554.2 | 467.45 | 408.37 | 252.19 | Upgrade
|
| Tangible Book Value Per Share | 3.36 | 6.53 | 6.86 | 7.43 | 5.27 | Upgrade
|
| Machinery | 0.25 | 0.25 | 0.25 | 0.54 | 0.41 | Upgrade
|
| Leasehold Improvements | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | Upgrade
|
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.